Skip to main content
Caplight Logo









Genosera Inc.

Genosera Inc.

Private
Columbus, OhioHealthcare & Life Scienceshttps://genosera.com

Last Round

Grant

Jul 31, 2023

Total Funding Raised

$150,000

Company Overview

Genosera Inc. operates in Healthcare & Life Sciences and is based in Columbus, Ohio. Its latest recorded funding round was a Grant round in July 2023.

Genosera Inc. is a biotechnology company that develops proprietary dual-gene AAV gene therapy treatments for rare neuromuscular and genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Genosera Inc. Comparables

Compare Genosera Inc. with similar companies based on industry and business-model similarity.

Genosera Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Orphina Biotechnology
87%
Atamyo Therapeutics
82%
Bayer AG
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Genosera Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 31, 2023
GrantJul 11, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Genosera Inc. Investors

Notable investors and investment history

Genosera Inc. investors
InvestorRounds
Ohio Third FrontierGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 31, 2023

    Received grant funding from Solve GNE.

Book a demo to see all signals

For institutional investors. Book with your work email.

Genosera Inc. Filings

Explore SEC and related filing metadata, where available.

Genosera Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Genosera Inc.'s valuation, stock price, and market status.

Is Genosera Inc. a public or private company?

Genosera Inc. is a private company.

What is the current stock price of Genosera Inc.?

Genosera Inc. is a private company, so its shares have no public market price. Caplight tracks Genosera Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Genosera Inc. worth (valuation)?

Valuation information for Genosera Inc. is not publicly available.

Can I buy Genosera Inc. stock?

Genosera Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Genosera Inc.'s last funding round?

Genosera Inc.'s most recent funding round was Grant on July 31, 2023.

Who are the main investors in Genosera Inc.?

Key investors in Genosera Inc. include Ohio Third Frontier.

Will Genosera Inc. IPO soon?

No public IPO plans have been announced for Genosera Inc..

How can I track Genosera Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Genosera Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersColumbus, Ohio
Year Founded2019
Last FundingJul 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?